AGN - 3 Dividend Stocks Weathering the Coronavirus Storm
In the coronavirus-fueled bear market, finding a dividend stock that hasn't taken a major hit is akin to searching for the Holy Grail. Companies have been slashing dividends right and left, leaving some investors to wonder whether it's even worth it to buy dividend-paying stocks right now. While there are valid arguments for both the pros and cons of dividend investing in the COVID-19 market, there are still strong dividend stocks to be found for investors with a long-term buying philosophy in mind.
No stock is 100% recession-proof. That said, by investing in high-paying dividend stocks holding steadfast in the bear market, you can still enjoy solid dividend income in these uncertain times and the recovery period to follow. And by scooping up more shares of safe dividend-paying stocks, you can enjoy a significant return on your investment once the market rights again.
In particular, Novartis (NYSE: NVS), AbbVie (NYSE: ABBV), and Amgen (NASDAQ: AMGN) have risen to the forefront as attractive buying opportunities since the coronavirus market crash. Not only does each company have a consistent history of increasing or maintaining its dividend year after year, but each has experienced relatively low volatility during these unprecedented times.